CryoLife, Inc. (CRY)
(Delayed Data from NYSE)
$31.42 USD
-0.08 (-0.25%)
Updated May 3, 2019 04:02 PM ET
After-Market: $31.42 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$31.42 USD
-0.08 (-0.25%)
Updated May 3, 2019 04:02 PM ET
After-Market: $31.42 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Wall Street Analysts Think CryoLife (CRY) Could Surge 51%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for CryoLife (CRY) points to a 50.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CryoLife (CRY) Tops Q3 Earnings Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of 420.00% and -0.95%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: CryoLife (CRY) Q3 Earnings Expected to Decline
by Zacks Equity Research
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoLife (CRY) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of -20.00% and 5.76%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
CryoLife (CRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CryoLife (CRY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoLife (CRY) Soars 24.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
CryoLife (CRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CryoLife (CRY) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of 27.27% and 15.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: CryoLife (CRY) Q1 Earnings Expected to Decline
by Zacks Equity Research
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoLife (CRY) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of 1100.00% and 4.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
CryoLife (CRY) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of 1400.00% and 12.49%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
CryoLife (CRY) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of 33.33% and 4.82%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoLife (CRY) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of -500.00% and 1.26%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoLife Wins CE Mark, Boosts Mechanical Valve Foothold in EU
by Zacks Equity Research
CryoLife's (CRY) On-X AAP completes the company's On-Xs heart valve portfolio.
CryoLife (CRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Carrols, Braskem, FirstService and CryoLife
by Zacks Equity Research
Zacks.com featured highlights include: Carrols, Braskem, FirstService and CryoLife
5 Toxic Stocks to Disown or Play Short to Book Profits
by Zacks Equity Research
Figuring out bloated toxic stocks on a regular basis and discarding them at the right time is the key to successful investing.
CryoLife (CRY) Q3 Earnings Top Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of 50.00% and -1.91%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoLife Enters Agreement With Endospan for Aortic Stent
by Zacks Equity Research
CryoLife (CRY) eyes to expand the portfolio of aortic care, with endovascular stent graft system.
4 Toxic Stocks to Abandon or Sell Short for Solid Gains
by Zacks Equity Research
Overhyped toxic stocks are vulnerable to external shocks and burdened with huge amount of debt.
CryoLife (CRY) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CryoLife (CRY) delivered earnings and revenue surprises of 37.50% and 0.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CryoLife (CRY) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CryoLife (CRY) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.